Screening for coronary artery disease before renal transplantation-rational or rationing?

Transplantation

Volumn 89, Issue 7, 2010, Pages 807-808

  Mark, Patrick B ^a   Patel, Rajan K ^a   Jardine, Alan G ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; HEART SCINTISCANNING; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NOTE; PRIORITY JOURNAL; REVASCULARIZATION; RISK BENEFIT ANALYSIS; SCREENING; SURVIVAL;

BRAZIL; CARDIOVASCULAR DISEASES; CORONARY STENOSIS; DISEASE PROGRESSION; HEALTH CARE RATIONING; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MASS SCREENING; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 77950926855     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181cca6b6     Document Type: Note

References (6)

1. De Lima JJ, Gowdak LH, de Paula FJ, et al. Treatment of coronary artery diseaseinhemodialysis patients evaluated for transplant\A registry study. Transplantation 2010; 89: 845.
2. Kasiske BL, Malik MA, Herzog CA. Risk-stratified screening for isch-emic heart disease in kidney transplant candidates. Transplantation 2005; 80: 815.
3. Patel RK, Mark PB, Johnston N, et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: A single-center prospective observational study. Am J Transplant 2008; 8: 1673.
4. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503.
5. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascular-ization before elective major vascular surgery. N Engl J Med 2004; 351: 2795.
6. Fellstrom BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395.